CNSP Stock Analysis: Buy, Sell, or Hold?
CNSP - CNS Pharmaceuticals, Inc. Common Stock
$2.31
0.05 (2.02%)
▲
5d:
-6.46%
30d:
+1.78%
90d:
-60.37%
HOLD
LOW Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 21, 2026
21d
Get Alerted When CNSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNSP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CNSP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CNSP is currently trading at $2.31, which is considered slightly low relative to its 30-day fair value range of $2.24 to $2.61.
Technical Outlook: Technically, CNSP is in a strong downtrend. Immediate support is located at $1.90, while resistance sits at $2.89.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+341.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNSP is in a strong downtrend. Immediate support is located at $1.90, while resistance sits at $2.89.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+341.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.24 -
$2.61
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 341.6% below Wall St target ($10.00)
- CAUTION: Recommendation downgraded due to -6.5% 5-day decline
Trading Range Analysis
30-Day Trading Range
$2.24 -
$2.61
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.90
Resistance Level
$2.89
Current Trend
Strong Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.78
Wall Street Target
$10.00
(+341.6%)
Share & Embed Analysis
Last updated: April 29, 2026 9:52 AM ET
Data refreshes hourly during market hours. Next update: 10:52 AM
Data refreshes hourly during market hours. Next update: 10:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$99 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 53 HOLD |
